NAVXPRESS

Serial Number 97436697
Registration 7566017
700

Registration Progress

Application Filed
May 31, 2022
Under Examination
May 9, 2023
Approved for Publication
Mar 14, 2023
Published for Opposition
Mar 14, 2023
Registered
Nov 12, 2024

Trademark Image

NAVXPRESS

Basic Information

Serial Number
97436697
Registration Number
7566017
Filing Date
May 31, 2022
Registration Date
November 12, 2024
Published for Opposition
March 14, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 12, 2024
Registration
Registered
Classes
040 042

Rights Holder

REGENXBIO Inc.

03
Address
9804 Medical Center Drive
Rockville, MD 20850

Ownership History

REGENXBIO Inc.

Original Applicant
03
Rockville, MD

REGENXBIO Inc.

Owner at Publication
03
Rockville, MD

REGENXBIO Inc.

Original Registrant
03
Rockville, MD

Legal Representation

Attorney
William R. Samuels

USPTO Deadlines

Next Deadline
1943 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-11-12)
Due Date
November 12, 2030
Grace Period Ends
May 12, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

47 events
Date Code Type Description Documents
Dec 12, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 12, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 12, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Nov 12, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Nov 12, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 8, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Oct 8, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Aug 29, 2024 ALIE A ASSIGNED TO LIE Loading...
Aug 29, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 29, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 28, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 28, 2023 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Dec 28, 2023 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Sep 29, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 29, 2023 GNRT O NON-FINAL ACTION E-MAILED Loading...
Sep 29, 2023 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Aug 26, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Aug 26, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 21, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Aug 21, 2023 IUAF S USE AMENDMENT FILED Loading...
Jun 17, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 17, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 17, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 17, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 17, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 17, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 17, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 17, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 17, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 9, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 14, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 14, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 22, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 7, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 6, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 6, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 6, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Feb 6, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 25, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 25, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 25, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 6, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 6, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 6, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 25, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 8, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 3, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 040
Custom manufacture of reagents for scientific and medical research and development; Custom manufacturing services, namely, production for others of clinical and medical reagents for use in gene therapy, for development of pharmaceutical preparations for use in gene therapy, and of therapeutic compositions that include recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy, including gene therapy delivery of antibody biologics, enzymes and RNA interference (RNAi)
First Use Anywhere: Jun 9, 2022
First Use in Commerce: Mar 14, 2023
Class 042
Custom design and development of reagents for scientific and medical research and development
First Use Anywhere: Jun 9, 2022
First Use in Commerce: Mar 14, 2023

Classification

International Classes
040 042